The cost-effectiveness of vaccination against lyme disease
Vaccination against Lyme disease appears to be safe and effective; however, the cost per quality-adjusted life-year (QALY) gained with vaccination is unknown. The authors developed a decision-analytical model to evaluate cost-effectiveness of vaccination compared with no vaccination in individuals living in endemic areas of Lyme disease.
Year:
2001
Publisher:
Arch Intern Med 161(4) pp554-61.
Reference:
Shadick, N.A., Liang, M.H., Phillips, C.B. K. Fossel and K.M. Kunz (2001) “The cost-effectiveness of vaccination against lyme disease” Arch Intern Med 161(4) pp554-61.
Geographical area:
Scale:
Policy areas considered: